These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9823427)

  • 1. Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.
    Kim J; Zhi J; Satoh H; Koss-Twardy SG; Passe SM; Patel IH; Pazdur R
    Anticancer Drugs; 1998 Sep; 9(8):689-96. PubMed ID: 9823427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C; Louvet C; de Gramont A; Lucchi E; Seitz JF; Mal F; Raymond E; Cady J; Carola E; Krulik M
    Cancer; 1997 Mar; 79(6):1094-9. PubMed ID: 9070485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
    Pazdur R; Ajani JA; Patt YZ; Gomez J; Bready B; Levin B
    Cancer; 1993 Feb; 71(4):1214-8. PubMed ID: 8435795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules.
    John WJ; Neefe JR; Macdonald JS; Cantrell J; Smith M
    Cancer; 1993 Dec; 72(11):3191-5. PubMed ID: 8242541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation.
    Sparano JA; Wadler S; Diasio RB; Zhang R; Lu Z; Schwartz EL; Einzig A; Wiernik PH
    J Clin Oncol; 1993 Aug; 11(8):1609-17. PubMed ID: 8336197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer.
    Piga A; Cascinu S; Latini L; Marcellini M; Bavosi M; Acito L; Bascioni R; Giustini L; Francini G; Pancotti A; Rossi G; Del Papa M; Carle F; Cellerino R
    Br J Cancer; 1996 Sep; 74(6):971-4. PubMed ID: 8826868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.
    Greco FA; Figlin R; York M; Einhorn L; Schilsky R; Marshall EM; Buys SS; Froimtchuk MJ; Schuller J; Schuchter L; Buyse M; Ritter L; Man A; Yap AK
    J Clin Oncol; 1996 Oct; 14(10):2674-81. PubMed ID: 8874326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
    Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ
    Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of 5-fluorouracil, leucovorin and interferon-alpha 2b administered by 24 h infusion in metastatic colorectal carcinoma.
    Cascinu S; Del Ferro E; Ligi M; Catalano G
    Anticancer Drugs; 1996 Jul; 7(5):520-4. PubMed ID: 8862717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential biochemical modulation of fluorouracil with folinic acid, N-phosphonacetyl-L-aspartic acid, and interferon alfa-2a in advanced colorectal cancer.
    Royce ME; McGarry W; Bready B; Dakhil SR; Belt RJ; Goodwin JW; Gray R; Hoff PM; Winn R; Pazdur R
    J Clin Oncol; 1999 Oct; 17(10):3276-82. PubMed ID: 10506630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study.
    Dufour P; Husseini F; Dreyfus B; Cure H; Martin C; Prevost G; Olivier JP; Dumas F; Duclos B; Olivares R; Leszler A; Bergerat JP; Audhuy B; Thill L; Oberling F
    Ann Oncol; 1996 Aug; 7(6):575-9. PubMed ID: 8879370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
    Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
    Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.
    Kemeny N; Younes A; Seiter K; Kelsen D; Sammarco P; Adams L; Derby S; Murray P; Houston C
    Cancer; 1990 Dec; 66(12):2470-5. PubMed ID: 2249187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS; Mangalik A; Ferguson J; Elias L
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancer.
    Preiss J
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):220-4. PubMed ID: 1557652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP
    Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Knauf WU; Boese-Landgraf J; Schalhorn A; Zeitz M
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):197-203. PubMed ID: 1557647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.